Mankind Pharma Ltd has CRISIL AA+/Stable reaffirmed on ₹2,500 crore of NCDs, while ratings on ₹2,500 crore of NCDs and ₹1,500 crore of commercial paper were withdrawn.
- Reaffirmed rating covers NCDs of ₹400 crore and ₹2,100 crore.
- Withdrawn ratings were AA+/Stable on NCDs and A1+ on commercial paper.
- Disclosed under SEBI Listing Regulations.